Wikidata

(Q33203906)

English

Pegylated interferon-alpha2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrations

scientific article

In more languages

Statements

title
Pegylated interferon-alpha2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrations (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15205601
retrieved
23 July 2017
author name string
Arthur R Van Gool
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15205601
retrieved
23 July 2017
Heidi H van Ojik
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15205601
retrieved
23 July 2017
Wim H J Kruit
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15205601
retrieved
23 July 2017
Marjolein Bannink
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15205601
retrieved
23 July 2017
Paul G H Mulder
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15205601
retrieved
23 July 2017
Gerrit Stoter
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15205601
retrieved
23 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33203906&oldid=1985673645"